Cancer Institute A national cancer institute
designated cancer center

Philip W. Lavori

Publication Details

  • Background and rationale for the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study PSYCHIATRIC CLINICS OF NORTH AMERICA Fava, M., Rush, A. J., Trivedi, M. H., Nierenberg, A. A., Thase, M. E., Sackeim, H. A., Quitkin, F. M., Wisniewski, S., Lavori, P. W., Rosenbaum, J. F., Kupfer, D. J. 2003; 26 (2): 457-?


    Sequenced Treatment Alternatives to Relieve Depression (STAR*D) attempts to fill in major clinical information gaps and to evaluate the theoretical principles and clinical beliefs that currently guide pharmacotherapy of major depressive disorder. The study is conducted in representative participant groups and settings using clinical management tools that easily can be applied in daily practice. Outcomes include clinical outcomes and health care utilization and cost estimates. Research findings should be immediately applicable to, and easily implemented in, the daily primary and specialty care practices. This article provides the overall rationale for STAR*D and details the rationale for key design, measurement, and analytic features of the study.

    View details for DOI 10.1016/S0193-953X(02)00107-7

    View details for Web of Science ID 000182929300010

    View details for PubMedID 12778843

Stanford Medicine Resources:

Footer Links: